Literature DB >> 2987314

Biphenotypic leukaemia: a case of mixed T lymphoblastic and myeloblastic leukaemia.

M A Morgan, C S Scott, J Tavares de Castro, H J Limbert, N Polli, D Catovsky, R D Pyrah, B E Roberts.   

Abstract

A case of mixed acute leukaemia with T lymphoblastic, myeloblastic, and monocytic components is described. The use of immunological markers, ultrastructural morphology, cytochemistry, immunochemistry, and combined techniques, simultaneously detecting two markers in individual cells, made it possible to define the different blast cell populations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987314      PMCID: PMC499213          DOI: 10.1136/jcp.38.5.575

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  36 in total

1.  The association of nuclear blebs with aneuploidy in human acute leukemia.

Authors:  M J Ahearn; J M Trujillo; A Cork; A Fowler; J S Hart
Journal:  Cancer Res       Date:  1974-11       Impact factor: 12.701

2.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

3.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

4.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

Authors:  A J McMichael; J R Pilch; G Galfré; D Y Mason; J W Fabre; C Milstein
Journal:  Eur J Immunol       Date:  1979-03       Impact factor: 5.532

5.  A monoclonal antibody to human acute lymphoblastic leukaemia antigen.

Authors:  J Ritz; J M Pesando; J Notis-McConarty; H Lazarus; S F Schlossman
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

6.  Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. II. A hybridoma secreting antibody against an antigen expressed by human B and null lymphocytes.

Authors:  I G Beckman; J Bradley; D A Brooks; A Kupa; P J McNamara; M E Thomas; H Zola
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

7.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

8.  Terminal deoxynucleotidyl transferase as a hematopoietic cell marker.

Authors:  F J Bollum
Journal:  Blood       Date:  1979-12       Impact factor: 22.113

9.  A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells.

Authors:  J D Griffin; D Linch; K Sabbath; P Larcom; S F Schlossman
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

10.  Mixed lymphoblastic-myelomonoblastic leukemia in treated Hodgkin's disease.

Authors:  A G Prentice; A G Smith; K F Bradstock
Journal:  Blood       Date:  1980-07       Impact factor: 22.113

View more
  1 in total

1.  Biphenotypic leukaemia.

Authors:  A N Stark; C S Scott; R D Pyrah; B E Roberts
Journal:  J Clin Pathol       Date:  1986-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.